Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DINUTUXIMAB vs NAXITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DINUTUXIMAB vs NAXITAMAB: Safety Overview

Metric DINUTUXIMAB NAXITAMAB
Total FAERS Reports 676 45
Deaths Reported 141 4
Death Rate 20.9% 8.9%
Hospitalizations 247 18
Average Patient Age 12.1 yrs 6.6 yrs
% Female Patients 39.3% 47.0%
Manufacturer United Therapeutics Corporation Y-mAbs Therapeutics, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A